Traws Pharma Inc.
TRAW | NASDAQ
$0.49
-$0.05 (-8.50%)
Sep 18, 2026, 4:00 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 1.36 | -0.25 | -0.83 | -0.72 | -2.66 | -3.25 |
PEG Ratio | -0.01 | 0 | 1.77 | 0.13 | 0.05 | 0.04 |
PS Ratio | 3.33 | 61.01 | 69.65 | 60.13 | 189.92 | 354.10 |
PB Ratio | -14.78 | -0.44 | 1.48 | 0.48 | 0.93 | 13.25 |
P/FCF Ratio | -0.45 | -0.46 | -0.88 | -0.83 | -2.20 | -3.54 |
P/OCF Ratio | -0.51 | -0.46 | -0.88 | -0.83 | -2.20 | -3.54 |
OCF/S Ratio | -651.79 | -13.18K | -7.93K | -7.21K | -8.62K | -9.99K |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.92 |
Current Ratio | 0.72 | 2.16 | 2.46 | 4.89 | 9.06 | 1.97 |
Asset Turnover | 0.26 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -1.46K% | 172.85% | -177.55% | -66.99% | -35.05% | -407.40% |
Return on Assets | 86.37% | -219.03% | -83.53% | -48.17% | -29.13% | -125.87% |
Return on Invested Capital | 3.38K% | -367.47% | -150.77% | -62.65% | -33.42% | -250.81% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 94.69% | 100% | 100% | 100% | 100% |
Net Profit Margin | 328.67% | -24.19K% | -8.38K% | -8.39K% | -7.15K% | -10.89K% |
Pretax Profit Margin | 328.67% | -73.68K% | -8.38K% | -8.39K% | -7.15K% | -10.89K% |
Operating Profit Margin | -640.68% | -21.84K% | -8.98K% | -8.68K% | -7.3K% | -10.82K% |
FCF Margin | -744.44% | -13.18K% | -7.94K% | -7.21K% | -8.62K% | -10K% |
EBITDA Margin | -638.49% | -73.68K% | -8.97K% | -8.68K% | -7.29K% | -10.81K% |
Add to Watchlist
Select watchlists to add or remove TRAW